HOME
 
 
Home  >  Portfolio  >  Investment Portfolio  >  CorePharma

CorePharma

Middlesex, New Jersey
www.corepharma.com

CorePharma is a leading developer and manufacturer of solid dose generic pharmaceuticals, including prescription and over-the-counter products. The company currently has over 30 FDA-approved products on the market, with a pipeline of over 25 new products in various stages of development and regulatory approval. CorePharma’s product portfolio is well diversified, spanning the spectrum of therapeutic specialties, and includes controlled drug products as well as immediate and modified release dosage form products.